Bayesian Capital Management’s Oscar Health OSCR Stock Holding History

Bayesian Capital Management’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,500	Closed	-$166K	–	282
2026 Q1	$166K	Sell	14,500 -5,700	-28%	-$80.3K	0.2%	120
2025 Q4	$290K	Buy	+20,200	New	+$349K	0.67%	53
2025 Q3	–	Sell	-64,000	Closed	-$1.37M	–	733
2025 Q2	$1.37M	Buy	+64,000	New	+$951K	0.22%	139
2024 Q4	–	Sell	-55,316	Closed	-$1.17M	–	900
2024 Q3	$1.17M	Buy	+55,316	New	+$996K	0.14%	213
2024 Q2	–	Sell	-71,707	Closed	-$1.07M	–	998
2024 Q1	$1.07M	Buy	+71,707	New	+$982K	0.1%	271
2023 Q4	–	Sell	-14,377	Closed	-$80.1K	–	962
2023 Q3	$80.1K	Buy	+14,377	New	+$101K	0.01%	623
2023 Q1	–	Sell	-16,190	Closed	-$39.8K	–	1015
2022 Q4	$39.8K	Buy	+16,190	New	+$50.6K	0.01%	715
2022 Q1	–	Sell	-16,700	Closed	-$131K	–	877
2021 Q4	$131K	Buy	+16,700	New	+$210K	0.04%	334

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bayesian Capital Management's OSCR Position: Q2 2026 in Review

Bayesian Capital Management sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 14,500 shares — an estimated $166K sold.

Bayesian Capital Management first reported a position in OSCR in Q4 2021 and held it in 8 quarters. The position peaked at $1.37M in Q2 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Bayesian Capital Management reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
Bayesian Capital Management sold 14,500 Oscar Health shares in Q2 2026, an estimated $166K.
Bayesian Capital Management first reported a position in Oscar Health in Q4 2021 and held it in 8 quarters.
Bayesian Capital Management's Oscar Health position peaked at $1.37M in Q2 2025.
403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.